Clinical Trial Detail

NCT ID NCT01905813
Title Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Incyte Corporation
Indications

Hodgkin's lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia

non-Hodgkin lymphoma

hairy cell leukemia

Therapies

INCB040093 + Itacitinib

INCB040093

Age Groups: adult

No variant requirements are available.